Autologous serum 50%
Showing 1 - 25 of >10,000
PRP Trial in Prishtina (PRP plasma rich platelets, Autologous serum)
Enrolling by invitation
- PRP
- PRP plasma rich platelets
- Autologous serum
-
Prishtina, KosovoEye Hospital,University Center Clinic of Kosova
Jul 6, 2023
Corneal Cells of Groth Factor-enriched Plasma and Autologous
Recruiting
- Aniridia
- Peripheral venous blood sample
- Conjunctival impression
-
Paris, FranceHôpital Fondation A. de Rothschild
Dec 6, 2022
AST Combined With 0.05% Cyclosporin Eye Drop Improve Corneal
Completed
- Sjogren's Syndrome
- +2 more
- Autologous serum tears combined with 0.05% cyclosporin eye drop
-
Chengdu, Sichuan, ChinaHospital of Chengdu University of Traditional Chinese Medicine
Aug 25, 2023
Keratoconus, Keratoconus of Right Eye, Keratoconus, Unstable, Right Eye Trial in Pristina (Fresh corneal lenticule and
Active, not recruiting
- Keratoconus
- +2 more
- Fresh corneal lenticule and autologous serum in advanced keratoconus using ReLex Smile surgery
-
Pristina, KosovoEye Hospital Pristina
Jul 25, 2022
Corneal Epithelial Wound Trial in Banha, BaNHA (Insulin, autologous serum (AS), conventional)
Not yet recruiting
- Corneal Epithelial Wound
- Insulin
- +2 more
-
Banha, Kalyobeya, Egypt
- +1 more
Apr 15, 2022
Ulcer Venous Trial in Turin (Autologous extracellular vesicles from serum)
Recruiting
- Ulcer Venous
- Autologous extracellular vesicles from serum
-
Turin, ItalyAOU San Giovanni Battista
May 18, 2022
Corneal Epithelial Defect Trial in Riyadh (Amniotic membrane transplantation, Autologous serum/BSS 20%)
Completed
- Corneal Epithelial Defect
- Amniotic membrane transplantation
- Autologous serum/BSS 20%
-
Riyadh, Saudi ArabiaKing Khaled Eye Specialist Hospital
Nov 21, 2021
Dry Eye Syndromes, Sjogren Syndrome With Keratoconjunctivitis Trial in El Palomar (Amniotic membrane extract eye drops (AMEED))
Completed
- Dry Eye Syndromes
- Sjogren Syndrome With Keratoconjunctivitis
- Amniotic membrane extract eye drops (AMEED)
-
El Palomar, Buenos Aires, Argentina
- +2 more
Oct 24, 2022
Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma Trial in Milano (intralesional rituximab, supplemental autologous
Completed
- Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma
- intralesional rituximab
- supplemental autologous serum
-
Milano, ItalyDip. Oncoematologia - Fondazione Centro San Raffaele del Monte T
Aug 2, 2022
Adenoviral Keratoconjunctivitis Trial in Pristina (relex smile)
Active, not recruiting
- Adenoviral Keratoconjunctivitis
- relex smile
-
Pristina, KosovoEye Hospital Pristina
Nov 13, 2021
Spondylitis, Ankylosing Trial in Grenoble (Etanercept ® 50 mg)
Completed
- Spondylitis, Ankylosing
- Etanercept ® 50 mg
-
Grenoble, FranceUniversity Hospital Grenoble
Jun 13, 2022
Post-Concussion Syndrome Trial in La Mesa (50 Adipose Derived Stem Cell Infusion, 150 Adipose Derived Stem Cell Infusion, 300
Recruiting
- Post-Concussion Syndrome
- 50 Adipose Derived Stem Cell Infusion
- +3 more
-
La Mesa, CaliforniaBioSolutions Clinical Research Center
Feb 14, 2022
Dry Eye Disease Trial in Ratchathewi (100% Autologous platelet rich plasma, 100% Autologous serum)
Recruiting
- Dry Eye Disease
- 100% Autologous platelet rich plasma
- 100% Autologous serum
-
Ratchathewi, Bangkok, ThailandOphthalmology Department, Ramathibodi Hospital
Feb 24, 2021
Testosterone Deficiency Trial in New York (Clomiphene Citrate 25mg, Clomiphene Citrate 50mg)
Not yet recruiting
- Testosterone Deficiency
- Clomiphene Citrate 25mg
- Clomiphene Citrate 50mg
-
New York, New YorkWeill Cornell Medicine
Mar 24, 2022
Spinal Stenosis Lumbar, Spinal Canal Stenosis Trial in Warszawa (combination product, drug, procedure)
Active, not recruiting
- Spinal Stenosis Lumbar
- Spinal Canal Stenosis
- Goldic serum
- +2 more
-
Warszawa, Mazovia, PolandSutherland Medical Center
Mar 10, 2021
COPD Trial in Boston (Home noninvasive nocturnal ventilation with Breas VIVO 50 home ventilator or newer model as available,
Withdrawn
- COPD
- Home noninvasive nocturnal ventilation with Breas VIVO 50 home ventilator or newer model as available, Breas Medical.
- +2 more
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Jan 3, 2023
Beta-Thalassemia Trial in Worldwide (LentiGlobin BB305 Drug Product)
Active, not recruiting
- Beta-Thalassemia
- LentiGlobin BB305 Drug Product
-
Oakland, California
- +8 more
Feb 4, 2022
Ewing's Family Tumors, Renal Tumors, Hepatoblastoma Trial in Minneapolis (drug, biological, radiation, procedure)
Recruiting
- Ewing's Family Tumors
- +11 more
- Ifosfamide
- +13 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Apr 11, 2022
Cytokine Storm Trial in Amman (Vitamin D3)
Completed
- Cytokine Storm
- Vitamin D3
-
Amman, JordanMahmoud S Abu-Samak
Feb 23, 2022
Spinal Cord Injury at C5-Th10 Level With Complete Lesion, Spinal Cord Transection Trial in Wroclaw (obtaining of autologous
Recruiting
- Spinal Cord Injury at C5-Th10 Level With Complete Lesion
- Spinal Cord Transection
- obtaining of autologous human olfactory bulb, autologous sural nerve preparation
- +2 more
-
Wroclaw, PolandWroclaw Medical University
Nov 15, 2021
Epicondylitis, Lateral Trial in Sabadell, Barcelona (Autologous Cytokine Rich Serum, Arthroscopic Resection)
Recruiting
- Epicondylitis, Lateral
- Autologous Cytokine Rich Serum
- Arthroscopic Resection
-
Sabadell, Barcelona, Spain
- +1 more
Dec 23, 2020
Cognitive Change, Mood, Inflammatory Response Trial in Reading (Control, 50 g Walnut)
Completed
- Cognitive Change
- +4 more
- Control
- 50 g Walnut
-
Reading, Berkshire, United KingdomUniversity of Reading
Aug 16, 2021
Autoimmune Disease, Neurologic Autoimmune Disease, Autologous Transplant Autoimmune Trial in Denver, Seattle (biological,
Recruiting
- Autoimmune Disease
- +18 more
- Anti-Thymocyte Globulin
- +9 more
-
Denver, Colorado
- +2 more
Feb 1, 2023
Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma Trial (procedure, drug, biological, radiation, other)
Not yet recruiting
- Recurrent Classic Hodgkin Lymphoma
- Refractory Classic Hodgkin Lymphoma
- Autologous Hematopoietic Stem Cell Transplantation
- +13 more
- (no location specified)
Feb 2, 2023